FDA Becomes a Tool of Industrial Policy: Priority Vouchers, PreCheck and the 100% Pharma Tariff That Most Big Drugmakers Avoid
On 1 April 2026 the FDA approved Eli Lilly’s Foundayo, an obesity pill, 50 days after the company filed. Standard reviews take about ten months. The speed came from a Commissioner’s National Priority Voucher, a programme launched in June 2025 that promises …